NCT05842174 2026-04-16
TAQE
VA Office of Research and Development
Phase 1/2 Recruiting
Clinical Trials
11 trialsNCT06681220 2026-03-11
Relapsed SCLC
VA Office of Research and Development
Phase 1/2 Recruiting
NCT05467748 2026-01-27
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
VA Office of Research and Development
Phase 1/2 Recruiting
NCT05687721 2025-06-15
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
VA Office of Research and Development
Phase 1/2 Withdrawn
NCT06064279 2024-09-19
HAITEN-ICI
VA Office of Research and Development
Phase 1/2 Withdrawn
NCT04037462 2024-06-14
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
VA Office of Research and Development
Phase 1/2 Terminated
NCT01580696 2020-05-04
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
San Antonio Military Medical Center
Phase 1/2 Completed
NCT00953849 2017-03-07
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity
VA Office of Research and Development
Phase 1/2 Completed
NCT01324102 2016-01-01
YogaCares
VA Office of Research and Development
Phase 1/2 Completed
NCT01516489 2015-10-26
Improving Fecal Occult Blood Test Completion Rates Among Veterans
Corporal Michael J. Crescenz VA Medical Center
Phase 1/2 Completed
NCT00029328 2015-03-25
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
FDA Office of Orphan Products Development
Phase 1/2 Completed